Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Shattock

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
International Journal of Pharmaceutics|February 11, 2025
Targeted nasal delivery of LNP-mRNAs aerosolised by Rayleigh breakup technologyHao-Ying Li, Abhimata Paramanandana, Sally Yunsun Kim, et al.
Antiviral Research|April 27, 2007
In vitro anti-HIV and -HSV activity and safety of sodium rutin sulfate as a microbicide candidateJian Tao, Qinxue Hu, Jing Yang, et al.
NPJ Vaccines|April 30, 2021
Quality by design modelling to support rapid RNA vaccine production against emerging infectious diseasesDamien van de Berg, Zoltán Kis, Carl Fredrik Behmer, et al.
Vaccine|December 15, 2010
Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigenMauricio A Arias, Andrew Loxley, Christy Eatmon, et al.
Vaccine|July 13, 2025
Development of a live-attenuated vaccine challenge model of Yersinia pestis in humans: Expert consultation on clinical trial considerations, January 2025Anna Rydlova, Emma Smith, Arabella Stuart, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 12, 2016
Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure ProphylaxisJulie Fox, Juan M Tiraboschi, Carolina Herrera, et al.
Molecular Pharmaceutics|July 29, 2016
Transporters for Antiretroviral Drugs in Colorectal CD4+ T Cells and Circulating α4β7 Integrin CD4+ T Cells: Implications for HIV MicrobicidesIndrani Mukhopadhya, Graeme I Murray, Linda Duncan, et al.
Plos Medicine|August 8, 2008
Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gelMartin Cranage, Sally Sharpe, Carolina Herrera, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitisAsna A Siddiqui, Annemarie E Brouwer, Vannaporn Wuthiekanun, et al.
Frontiers in Cellular and Infection Microbiology|May 25, 2023
Comparative analysis of vaginal microbiota sampling using menstrual cups and high vaginal swabs in pregnant women living with HIV-1 infectionCharlotte-Eve S Short, Rachael Quinlan, Yun S Lee, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
International Journal of Pharmaceutics|February 11, 2025
Targeted nasal delivery of LNP-mRNAs aerosolised by Rayleigh breakup technologyHao-Ying Li, Abhimata Paramanandana, Sally Yunsun Kim, et al.
Antiviral Research|April 27, 2007
In vitro anti-HIV and -HSV activity and safety of sodium rutin sulfate as a microbicide candidateJian Tao, Qinxue Hu, Jing Yang, et al.
NPJ Vaccines|April 30, 2021
Quality by design modelling to support rapid RNA vaccine production against emerging infectious diseasesDamien van de Berg, Zoltán Kis, Carl Fredrik Behmer, et al.
Vaccine|December 15, 2010
Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigenMauricio A Arias, Andrew Loxley, Christy Eatmon, et al.
Vaccine|July 13, 2025
Development of a live-attenuated vaccine challenge model of Yersinia pestis in humans: Expert consultation on clinical trial considerations, January 2025Anna Rydlova, Emma Smith, Arabella Stuart, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 12, 2016
Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure ProphylaxisJulie Fox, Juan M Tiraboschi, Carolina Herrera, et al.
Molecular Pharmaceutics|July 29, 2016
Transporters for Antiretroviral Drugs in Colorectal CD4+ T Cells and Circulating α4β7 Integrin CD4+ T Cells: Implications for HIV MicrobicidesIndrani Mukhopadhya, Graeme I Murray, Linda Duncan, et al.
Plos Medicine|August 8, 2008
Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gelMartin Cranage, Sally Sharpe, Carolina Herrera, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitisAsna A Siddiqui, Annemarie E Brouwer, Vannaporn Wuthiekanun, et al.
Frontiers in Cellular and Infection Microbiology|May 25, 2023
Comparative analysis of vaginal microbiota sampling using menstrual cups and high vaginal swabs in pregnant women living with HIV-1 infectionCharlotte-Eve S Short, Rachael Quinlan, Yun S Lee, et al.
Pageof 6